百服咛品牌怎么样申请店铺

我要投票

百服咛在医疗保健行业中的票数：577 更新时间：2026-01-24

百服咛是哪个国家的品牌？「百服咛」是百时美施贵宝(中国)投资有限公司旗下著名品牌。该品牌发源于美国，由创始人Maryam Tirandaz在1998-11-09期间创立，经过多年的不懈努力和高速发展，现已成为行业的标杆品牌。

外推网助力百服咛品牌出海！将品牌入驻外推网，定制百服咛品牌推广信息，可以显著提高百服咛产品曝光，简直是跨境电商爆单神器！目前仅需1000元/年哦~

百时美施贵宝（中国）投资有限公司，百服咛，对乙酰氨基酚滴剂，创于1887年美国，专业科研为基础的全球性的从事医药保健及个人护理产品的多元化企业

百时美施贵宝是一家全球性的生物制药公司，紧紧履行其探索、开发和提供创新药物的使命，帮助患者战胜严重疾病。

在世界各地，公司的药物帮助数以百万计的患者战胜癌症、心血管疾病、乙肝、艾滋病毒/艾滋病、类风湿关节炎和精神疾病等疾病。

在百时美施贵宝，公司的生物制药战略独特地结合了大型制药公司的覆盖面和资源和成功生物技术公司的创业精神和灵活性。有了这个战略，公司专注于客户的需求，加快管线发展、促进销售增长和坚持成本管理。

公司跑赢了大部分大型制药公司，多元化公司和纯生物技术公司。公司一直履行给股东带来价值的承诺，至今已向股东支付了连续300多个季度的股息。

此外，自2002年以来，公司已经向患者提供了13种新药。在2012年，公司可能会有两个新批准的药物。

公司的研发机构被认为是行业有生产力的机构。珍珠链战略创新联盟、伙伴关系以及收购进一步增强了公司的实力。公司全系列的珍珠覆盖了许多主要疾病领域，包括癌症、心血管疾病、免疫学、神经科学和病毒学。

追求公司的使命同时也意味着公司正在努力为病人提供医疗保健。公司正在努力通过公共/私人合作伙伴关系，如保卫未来，来实现这一目标。公司开创性的$ 1.5亿美元的项目旨在帮助非洲战胜艾滋病毒/艾滋病。此外，通过公司的患者援助项目，公司在美国为相关有经济困难的患者免费提供药物。

保护自然资源也是公司其中一个主要的承诺。公司公司在世界各地的设施上都整合了能源管理、污染控制和其他措施以减少对环境的影响。

产品介绍

百服咛（对乙酰氨基酚滴剂），适应症为用于小儿普通感冒或流行性感冒引起的发热。

百服咛是由中美上海施贵宝生产的感冒药和解热镇痛药品牌。当前在中国，百服咛品牌旗下有一个成人感冒药产品日夜百服咛、一个成人止痛药产品加合百服宁和三个儿童退烧药产品儿童百服咛溶液/滴剂/咀嚼片。

Bristol Myers Squibb (China) Investment Co., Ltd., Bristol Myers and paracetamol drops, founded in 1887 in the United States, is a global diversified enterprise engaged in medical care and personal care products based on professional scientific research. Bristol Myers Squibb is a global bio pharmaceutical company. It closely performs its mission of exploring, developing and providing innovative drugs to help patients win the battle Heavy illness. Around the world, the company's drugs help millions of patients fight cancer, cardiovascular disease, hepatitis B, HIV / AIDS, rheumatoid arthritis and mental illness. At Bristol Myers Squibb, the company's biopharmaceutical strategy uniquely combines the coverage and resources of large pharmaceutical companies with the entrepreneurial spirit and flexibility of successful biotech companies. With this strategy, the company focuses on the needs of customers, accelerates pipeline development, promotes sales growth and adheres to cost management. The company outperformed most large pharmaceutical companies, diversified companies and pure biotechnology companies. The company has always fulfilled its promise of bringing value to shareholders and has paid dividends to shareholders for more than 300 consecutive quarters. In addition, since 2002, the company has provided 13 new drugs to patients. In 2012, the company may have two new approved drugs. The company's R & D institutions are considered to be productive in the industry. Pearl chain strategic innovation alliance, partnership and acquisition further enhance the strength of the company. The company's full range of pearls covers many major disease areas, including cancer, cardiovascular disease, immunology, neuroscience and virology. Pursuing the company's mission also means that the company is trying to provide medical care for patients. The company is working to achieve this through public / private partnerships, such as safeguarding the future. The company's groundbreaking $150 million project aims to help Africa fight HIV / AIDS. In addition, through the company's patient assistance program, the company provides free drugs to patients with financial difficulties in the United States. Protecting natural resources is also one of the company's main commitments. The company integrates energy management, pollution control and other measures at its facilities around the world to reduce the impact on the environment. Product introduction: Baifu (paracetamol drop) is used for fever caused by children's common cold or influenza. Baifu exhortation is a brand of cold medicine and antipyretic analgesics produced by Shiguibao in Shanghai, China and the United States. At present, in China, one adult cold medicine product, one adult painkiller product and three children's antipyretic products, children's Baifu solution / drops / chewable tablets are under the Baifu brand.

本文链接： https://brand.waitui.com/cfbb24990.html 联系电话：请联系客服添加联系邮箱：请联系客服添加